| 000 | 01066 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515175901.0 | ||
| 264 | 0 | _c20091022 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2009.03435.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGatt, A | |
| 245 | 0 | 0 |
_aOptimizing warfarin reversal--an ex vivo study. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cJul 2009 |
||
| 300 |
_a1123-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
| 700 | 1 | _aRiddell, A | |
| 700 | 1 | _avan Veen, J J | |
| 700 | 1 | _aKitchen, S | |
| 700 | 1 | _aTuddenham, E G | |
| 700 | 1 | _aMakris, M | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 7 _gno. 7 _gp. 1123-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2009.03435.x _zAvailable from publisher's website |
| 999 |
_c18991763 _d18991763 |
||